STXBP1 Encephalopathy Market Assessment 2024: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access
10 sept. 2024 11h29 HE
|
Research and Markets
Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "STXBP1 Encephalopathy Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access" report has been...
Botulinum Toxin Market Research 2024 - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts to 2031
06 août 2024 09h12 HE
|
Research and Markets
Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "Botulinum Toxin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
Dementia with Diabetes Pipeline Therapeutics Market Report 2024: Comprehensive Insights About 5+ Companies and 5+ Pipeline Drugs
17 juil. 2024 09h09 HE
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Dementia with Diabetes - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024, Featuring Sanofi, Bristol Myers Squibb, Abbott Laboratories, Takeda Pharmaceutical and Amgen
08 mars 2024 04h28 HE
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The chemotherapy...
Epilepsy Epidemiology 10 Year Forecast Report to 2032
25 janv. 2024 07h20 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Epilepsy - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.The report delivers an in-depth understanding of...
Chemotherapy Induced Peripheral Neuropathy Treatment Market to Surge to $2.06 Billion by 2027, New Research Shows
23 janv. 2024 02h38 HE
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The...
Global Market for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders: 2022-23 Data, Forecasts for 2024- 2026 and CAGR Projections through 2028
22 déc. 2023 05h03 HE
|
Research and Markets
Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders" report has been added to ResearchAndMarkets.com's offering. ...
Sleep Disorders Treatment Global Market Report 2023: Featuring Jazz Pharmaceuticals, Pfizer, Sanofi, Zydus Cadila Group & More
19 avr. 2023 04h33 HE
|
Research and Markets
Dublin, April 19, 2023 (GLOBE NEWSWIRE) -- The "Sleep Disorders Treatment: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. The report covers the market for...
Global Neuroprotection Markets to 2030: Major World Markets, Promising Areas of Research, Biological Therapies, Unmet Needs
23 nov. 2021 06h18 HE
|
Research and Markets
Dublin, Nov. 23, 2021 (GLOBE NEWSWIRE) -- The "Neuroprotection - Methods, Drugs, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This...
2021 U.S. Parkinson's Disease Epidemiology Report: 10-year Forecasts of Parkinson's Disease Epidemiology
23 août 2021 04h18 HE
|
Research and Markets
Dublin, Aug. 23, 2021 (GLOBE NEWSWIRE) -- The "Parkinson's Disease - US Epidemiology Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. The report delivers an...